Evaluation of a Generic Bortezomib Molecule in Newly Diagnosed Multiple Myeloma Patients
Objective: Constantly increasing health expenditures lead use of generic molecules and generics of bortezomib have been used for a long time. The aim of this study is to retrospectively examine the effectiveness, side effects and reliability of generic bortezomib in newly diagnosed multiple myeloma...
Main Authors: | Sinan Mersin, Ayfer Gedük, Özgür Mehtap, Pınar Tarkun, Serkan Ünal, Merve Gökçen Polat, Kemal Aygün, Emel Merve Yenihayat, Hayrunnisa Albayrak, Abdullah Hacıhanefioğlu |
---|---|
Format: | Article |
Language: | English |
Published: |
Galenos Publishing House
2021-08-01
|
Series: | Turkish Journal of Hematology |
Subjects: | |
Online Access: | https://jag.journalagent.com/z4/download_fulltext.asp?pdir=tjh&un=TJH-56750 |
Similar Items
-
Effectiveness of bortezomib and bortezomib-containing programs FOR the treatment of recurrent and resistant multiple myeloma
by: T A Mitina, et al.
Published: (2010-07-01) -
Progress on the Application of Bortezomib and Bortezomib-Based Nanoformulations
by: Jianhao Liu, et al.
Published: (2021-12-01) -
Why bortezomib cannot go with ‘green’?
by: Li Jia, et al.
Published: (2013-12-01) -
Bortezomib-induced hyponatremia: tolvaptan therapy permits continuation of lenalidomide, bortezomib and dexamethasone therapy in relapsed myeloma
by: N. O’Connor-Byrne, et al.
Published: (2019-02-01) -
A feline case of multiple myeloma treated with bortezomib
by: Hiroyuki Tani, et al.
Published: (2022-11-01)